Concepedia

LBA56 MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naïve (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial

M-J. Ahn, S-W. Kim, Laura Rodríguez, Jorge Oliveira, M.A. Insa Molla, Margarita Majem, Luís Costa, Wu‐Chou Su, K.H. Lee, James Chih‐Hsin Yang,

Annals of Oncology · 2022 · 21 citations · 0 references

Open access

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMedical OncologyCombination ChemotherapyCytotoxic ChemotherapyLung CancerLung Cancer PharmacotherapyTargeted Cancer TherapyTargeted TherapyNon-small Cell Lung Cancer Adjuvant TherapyNon-small Cell Lung Cancer ImmunotherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentPembrolizumab TherapyTargeted Combination Chemotherapy